Johnson & Johnson plans to launch its new consumer health firm, Kenvue, covering household names including Neutrogena, Band-Aid, and Johnson's Baby Powder.
It was made clear in 2021 that the company wanted to divide into two separate divisions, with the first business concentrating on consumer brands and the second on over-the-counter medications and medical equipment. Lat year, the consumer health category achieved $14.6 billion in sales.
“Johnson & Johnson plans to launch its new consumer health firm, Kenvue“
The selected Chief Executive Officer of Kenvue, Thibaut Mongon, said that “unveiling the Kenvue brand is a defining moment for our stakeholders and an important part of the planned separation.”
One of the most significant changes with the rebrand is the companies controversial baby powder, with J&J stating in August that it will stop producing and marketing talc-based baby powder products by 2023, switching to alternatives using corn-starch as the main ingredient.
There have been countless complaints and over 40,000 claims alleging that the original baby powder contributed to giving people ovarian cancer or mesothelioma, brought on by being in contact with asbestos.
Johnson & Johnson said that they “continuously evaluate and optimize our portfolio to best position the business for long-term growth. This transition will help simplify our product offerings, deliver sustainable innovation, and meet the needs of our consumers, customers and evolving global trends.”
© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.See all the latest jobs in Consumer